Virginia S. Hahn

2.9k total citations · 2 hit papers
29 papers, 1.6k citations indexed

About

Virginia S. Hahn is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Virginia S. Hahn has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Virginia S. Hahn's work include Cardiovascular Function and Risk Factors (10 papers), Heart Failure Treatment and Management (9 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Virginia S. Hahn is often cited by papers focused on Cardiovascular Function and Risk Factors (10 papers), Heart Failure Treatment and Management (9 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Virginia S. Hahn collaborates with scholars based in United States, Austria and Chile. Virginia S. Hahn's co-authors include David A. Kass, Bonnie Ky, Daniel J. Lenihan, Kavita Sharma, Dong I. Lee, Francisco Altamirano, Nan Jiang, Zhao V. Wang, Soo Young Kim and Joseph A. Hill and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Virginia S. Hahn

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitrosative stress drives heart failure with preserved ejection fraction

2019 548 citations Gabriele G. Schiattarella, Francisco Altamirano et al. Nature profile →
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction

2023 126 citations Virginia S. Hahn, Kenneth Bedi et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Virginia S. Hahn United States	13	1.1k	527	251	205	154	29	1.6k
Nathalie Mougenot France	26	683 0.6×	948 1.8×	164 0.7×	208 1.0×	223 1.4×	70	1.8k
Robert M. Blanton United States	24	1.2k 1.1×	1.0k 2.0×	374 1.5×	132 0.6×	248 1.6×	56	2.1k
Michinari Nakamura United States	17	1.1k 1.0×	1.3k 2.4×	362 1.4×	102 0.5×	342 2.2×	31	2.4k
Edoardo Bertero Germany	17	811 0.7×	880 1.7×	228 0.9×	97 0.5×	189 1.2×	38	1.7k
Rebecca S. Keller United States	19	597 0.5×	704 1.3×	147 0.6×	161 0.8×	111 0.7×	34	1.6k
Xiaoyan Qi China	26	1.3k 1.2×	935 1.8×	202 0.8×	121 0.6×	149 1.0×	67	2.2k
Xiaoying Zhang United States	21	721 0.7×	968 1.8×	118 0.5×	64 0.3×	195 1.3×	39	1.5k
Karima Ait‐Aissa United States	18	319 0.3×	384 0.7×	347 1.4×	43 0.2×	110 0.7×	43	1.0k
Yu‐Pei Yuan China	23	1.2k 1.1×	1.2k 2.2×	322 1.3×	356 1.7×	191 1.2×	31	2.4k
Si‐Chi Xu China	20	874 0.8×	930 1.8×	305 1.2×	260 1.3×	150 1.0×	28	1.9k

Countries citing papers authored by Virginia S. Hahn

Since Specialization

Citations

This map shows the geographic impact of Virginia S. Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia S. Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia S. Hahn more than expected).

Fields of papers citing papers by Virginia S. Hahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia S. Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia S. Hahn. The network helps show where Virginia S. Hahn may publish in the future.

Co-authorship network of co-authors of Virginia S. Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia S. Hahn. A scholar is included among the top collaborators of Virginia S. Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia S. Hahn. Virginia S. Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jani, Vivek, Edwin Yoo, Aleksandra Binek, et al.. (2025). Myocardial Proteome in Human Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 14(6). e038945–e038945. 5 indexed citations

Hahn, Virginia S., Ruin Moaddel, Min Zhu, et al.. (2025). Proteomic signature of HIV-associated subclinical left atrial remodeling and incident heart failure. Nature Communications. 16(1). 610–610. 3 indexed citations

Hahn, Virginia S., et al.. (2025). Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets. Current Treatment Options in Cardiovascular Medicine. 27(1). 65–65.

Koleini, Navid, Mohammad Keykhaei, Ting Liu, et al.. (2025). ATP-Citrate Lyase Supports Cardiac Function and NAD+/NADH Balance and Is Depressed in Human Failing Myocardium. JACC Basic to Translational Science. 10(7). 101301–101301.

Koleini, Navid, Aleksandra Binek, Mohammad Keykhaei, et al.. (2024). Myocardial ultrastructure of human heart failure with preserved ejection fraction. Nature Cardiovascular Research. 3(8). 907–914. 15 indexed citations

Hahn, Virginia S., Senthil Selvaraj, Kavita Sharma, & Svati H. Shah. (2024). Towards Metabolomic-Based Precision Approaches for Classifying and Treating Heart Failure. JACC Basic to Translational Science. 9(9). 1144–1158. 9 indexed citations

Koleini, Navid, Liang Zhao, Mohammad Keykhaei, et al.. (2024). Landscape of Glycolytic Metabolites and Their Regulating Proteins in Myocardium from Human Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 26(9). 1941–1951. 10 indexed citations

Hahn, Virginia S., et al.. (2023). Abstract 14658: Echocardiographic Metrics Before Coronary Artery Bypass Grafting Are Associated With Postoperative Kidney Injury in Patients With Preserved Ejection Fraction, and Mean Perfusion Pressure May Mediate This Relationship. Circulation. 148(Suppl_1). 1 indexed citations

Thakkar, Aarti, Virginia S. Hahn, Nisha A. Gilotra, et al.. (2023). Sulfasalazine Hypersensitivity Reaction Induced Eosinophilic Myocarditis. Journal of Cardiac Failure. 29(4). 702–703.

10.

Trivedi, Rishi, et al.. (2022). Cystatin C Predicts Adverse Outcomes In Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure. 28(5). S80–S81. 1 indexed citations

11.

Hahn, Virginia S., Kathleen W. Zhang, Lova Sun, et al.. (2021). Heart Failure With Targeted Cancer Therapies. Circulation Research. 128(10). 1576–1593. 46 indexed citations

12.

Vaishnav, Joban, Lisa R. Yanek, Virginia S. Hahn, et al.. (2021). Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials. Journal of Cardiac Failure. 28(5). 723–731. 12 indexed citations

13.

Hahn, Virginia S., Hildur Knútsdóttir, Xin Luo, et al.. (2020). Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction. Circulation. 143(2). 120–134. 156 indexed citations

14.

Schiattarella, Gabriele G., Francisco Altamirano, Dan Tong, et al.. (2019). Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 568(7752). 351–356. 548 indexed citations breakdown →

15.

Yousefi, Keyvan, Lauro M Takeuchi, Wen Ding, et al.. (2019). Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway. Journal of the American College of Cardiology. 73(21). 2705–2718. 44 indexed citations

16.

Hahn, Virginia S., et al.. (2016). Role of Statins in Glucose Homeostasis and Insulin Resistance. Current Cardiovascular Risk Reports. 10(12). 2 indexed citations

17.

Hahn, Virginia S., Mary Putt, Heloisa Sawaya, et al.. (2015). LONGITUDINAL CHANGES IN MULTIPLE BIOMARKERS ARE ASSOCIATED WITH CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH DOXORUBICIN, TAXANES AND TRASTUZUMAB. Journal of the American College of Cardiology. 65(10). A1001–A1001. 4 indexed citations

18.

Hahn, Virginia S., et al.. (2015). A Report of Accelerated Coronary Artery Disease Associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. SHILAP Revista de lepidopterología. 2015. 1–3. 8 indexed citations

19.

Putt, Mary, Virginia S. Hahn, James L. Januzzi, et al.. (2015). Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab. Clinical Chemistry. 61(9). 1164–1172. 118 indexed citations

20.

Seo, Kinya, Peter P. Rainer, Virginia S. Hahn, et al.. (2014). Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proceedings of the National Academy of Sciences. 111(4). 1551–1556. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact